• Print

Hospital Joan XXIII and ICO Camp de Tarragona reach 250 autologous hematopoietic stem cell transplants

The first transplant of this type carried out at the Hospital Joan XXII was conducted in the year 1999. This procedure consists of administering high doses of chemotherapy and then transfusing the patient’s own stem cells that have been extracted previously. The Haematology Service at the Joan XXIII University Hospital has been managed, since October 2014, by the Catalan Institute of Oncology under the ICO Camp de Tarragona denomination.

14/07/2017 09:07
Hospital Joan XXIII

Coinciding with the commemoration of the 50th anniversary of the Joan XXIII University Hospital, the health centre’s Haematology Service, managed by ICO Camp de Tarragona, has reached 250 transplants using patients’ own stem cells, also called autologous hematopoietic stem cell transplants (HSCT). The first transplant of this type carried out at the Hospital Joan XXII was conducted in the year 1999, and since then, the number of HSCTs has progressively increased. During the year 2016, 24 were conducted, while this year over 30 are programmed.

The Haematology Service at the Joan XXIII University Hospital of Tarragona has been managed, since October 2014, by the Catalan Institute of Oncology under the ICO Camp de Tarragona denomination. This service is accredited by the Catalan Transplants Organisation and is the only centre in the Tarragona districts that carries out autologous hematopoietic stem cell transplants (auto-HSCT) in patients with diverse malignant haematological diseases.

Autologous hematopoietic stem cell transplants (Auto-HSCT)
The auto-HSCT is a procedure used to intensify the good response obtained previously with the specific treatment for each illness. It consists of transfusing into the patient their own autologous stem cells once they have received the appropriate chemotherapy (conditionally). This type of autologous transplant is recommended above all for illnesses such as Multiple Myeloma and some lymphomas. Occasionally, it can also be carried out with some types of acute leukaemia.

In order to carry out the auto-transplant great coordination is required between the Haematology Service, the Clinical Laboratory and the Blood and Tissues Bank (BTS). In addition, it must be carried out in a hospital that has access to different medical and surgical specialities. In this process the role of the nursing team is key.

From the Joan XXIII University Hospital to the ICO Camp de Tarragona
In the year 2014, the Haematology Service at the Joan XXIII University Hospital of Tarragona was transferred to the Catalan Institute of Oncology under the ICO Camp de Tarragona denomination.

Currently the Haematology Service has a staff team formed by 10 haematologists, 4 resident physicians (one per year), a specialised nursing team and one administration assistant.

The service offers diagnosis, treatment and monitoring of all blood disorders such as: acute leukaemia, myeloplastic syndrome, lymphoma, lymphoproliferative syndrome, multiple myeloma, bone marrow aplasia as well as benign haemopathies and coagulation disorders/controls.
The Haematology Service is accredited by the Catalan Transplants Organisation and is the only centre in the Tarragona area that carries out autologous hematopoietic stem cell transplants (auto-HSCT) in patients with different malignant haematological diseases.